India may soon train select countries on best drug regulatory practices

The project will be an extension of the CDSCO and NIHFW's ongoing training programmes with drug inspectors from the central and state drug authorities

drugs, pharma
NIHFW director Dheeraj Shah said that these trainings are focused on improving skills, knowledge, inspections, investigations, and the review of dossiers by drug inspectors.
Sanket Koul New Delhi
3 min read Last Updated : Mar 26 2025 | 8:26 PM IST
India may soon start training drug regulators from select foreign countries on drug regulatory practices and pharmacovigilance, officials in the know said on Wednesday.
 
The project could include drug regulators and inspectors from African, South East Asian, and South Asian Association for Regional Cooperation (SAARC) countries on drug and regulatory aspects and the sharing of expertise as part of the Ministry of External Affairs’ (MEA’s) International Training and Education Center for Health (ITECH) programme.
 
“A proposal for the same has been forwarded to the MEA, with the body expecting to get an approval for the programme soon,” an official from the Central Drugs Standard Control Organisation (CDSCO) said.
 
As part of the programme, countries would be informed on how the quality of drugs is monitored through market surveillance, where drug samples are drawn randomly from the market and manufacturing facilities and tested at government laboratories.
 
These training programmes will be held at the National Institute of Health and Family Welfare (NIHFW), an autonomous organisation under the Union health ministry, which has proposed training programmes for the drug regulators.
 
“Training would be imparted on the various aspects of vaccine and drug trials, drug testing laboratories, and marketing authorisation procedures for new vaccines, biologicals, and drugs,” the official said.
 
He also added that, as part of the proposal, the expenditure for the programme would be borne by the Centre.
 
The project will be an extension of the CDSCO and NIHFW’s ongoing training programmes with drug inspectors from the central and state drug authorities.
 
In the last two years, 1,477 drug regulators from the CDSCO and states have been trained on various drug regulatory aspects at the residential programmes at NIHFW.
 
Besides, 672 state drug regulators were also trained across the country in the last two years.
 
NIHFW director Dheeraj Shah said that these trainings are focused on improving skills, knowledge, inspections, investigations, and the review of dossiers by drug inspectors.
 
“The enhanced quality of investigations and prosecution has led to an increased conviction rate by 5 to 10 per cent over the last two years,” the official added.
 
Moreover, the CDSCO has also conducted various workshops across the country on the revised Schedule M standards for good manufacturing practices (GMP), which were attended by 39,107 industry representatives in the last two years.
 
“We are expecting to train another 800 people at NIHFW in the financial year (FY) 2025-26,” he said.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :pharma marketPharma industry

First Published: Mar 26 2025 | 8:26 PM IST

Next Story